Company logo

BIOL - BIOLASE, Inc.

NASDAQ -> Healthcare -> Medical Devices
Foothill Ranch, United States
Type: Equity

BIOL price evolution
BIOL
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $9.96 $19.55 $21.81 $30.18
Short term investments
Net receivables $4.85 $6.08 $5.18 $4.24
Inventory $16.43 $16.57 $14.61 $12.93
Total current assets $33.88 $44.27 $43.78 $49.35
Long term investments
Property, plant & equipment $5.82 $3.42 $3.3 $2.78
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $8.98 $6.59 $6.46 $5.93
Total investments
Total assets $42.87 $50.85 $50.24 $55.28
Current liabilities
Accounts payable $4.97 $4.96 $4.64 $3.31
Deferred revenue $2.22 $2.82 $2.75 $2.59
Short long term debt
Total current liabilities $13.76 $13.95 $13.11 $13.84
Long term debt $14.22 $14.32 $15.33 $15.05
Total noncurrent liabilities $15.24 $15.29 $16.53 $16.23
Total debt $14.22 $14.32 $15.33 $15.05
Total liabilities $29.01 $29.24 $29.64 $30.08
Shareholders' equity
Retained earnings -$286.31 -$277.92 -$272.31 -$267.53
Other shareholder equity -$1.04 -$0.89 -$0.66 -$0.62
Total shareholder equity $13.86 $21.61 $20.6 $25.21
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $30.18 $17.88 $6.1 $8.36
Short term investments
Net receivables $4.24 $3.06 $8.76 $11.11
Inventory $12.93 $11.16 $10.99 $12.25
Total current assets $49.35 $35.11 $27.02 $33.31
Long term investments
Property, plant & equipment $2.78 $2.76 $1.47 $1.98
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $5.93 $5.92 $4.83 $5.21
Total investments
Total assets $55.28 $41.02 $31.85 $38.52
Current liabilities
Accounts payable $3.31 $2.65 $5.33 $5.95
Deferred revenue $2.59 $2.28 $2.6 $2.48
Short long term debt $13.47
Total current liabilities $13.84 $11.22 $25.78 $15.97
Long term debt $15.05 $17.96 $10.84
Total noncurrent liabilities $16.23 $19.77 $1.73 $11.46
Total debt $15.05 $17.96 $13.47 $10.84
Total liabilities $30.08 $31 $27.5 $27.43
Shareholders' equity
Retained earnings -$267.53 -$251.38 -$234.55 -$216.69
Other shareholder equity -$0.62 -$0.39 -$0.7 -$0.67
Total shareholder equity $25.21 $10.03 $0.38 $11.09
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $12.01 $12.23 $10.17 $12.41
Cost of revenue $9.56 $7.09 $5.44 $7.5
Gross Profit $2.44 $5.14 $4.73 $4.91
Operating activities
Research & development $1.98 $1.65 $1.54 $1.54
Selling, general & administrative $8.12 $8.54 $7.39 $7.67
Total operating expenses $10.1 $10.2 $8.94 $9.34
Operating income -$7.65 -$5.05 -$4.21 -$4.43
Income from continuing operations
EBIT -$7.98 -$5.16 -$4.33 -$4.71
Income tax expense -$0.02 $0.02 $0.02 $0.07
Interest expense $0.42 $0.43 $0.43 $0.5
Net income
Net income -$8.39 -$5.61 -$4.78 -$5.28
Income (for common shares) -$8.39 -$5.61 -$4.78 -$5.28
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $39.19 $22.78 $37.8 $46.16
Cost of revenue $22.66 $16.61 $23.51 $29.26
Gross Profit $16.53 $6.17 $14.29 $16.89
Operating activities
Research & development $6.05 $3.69 $4.76 $5.2
Selling, general & administrative $26.6 $21.01 $25.14 $29.89
Total operating expenses $32.96 $24.71 $29.91 $37.78
Operating income -$16.43 -$18.54 -$15.62 -$20.89
Income from continuing operations
EBIT -$13.87 -$14.34 -$15.74 -$20.94
Income tax expense $0.07 $0.13 -$0.04 $0.06
Interest expense $2.22 $2.36 $2.16 $0.51
Net income
Net income -$16.16 -$16.83 -$17.86 -$21.52
Income (for common shares) -$16.16 -$16.83 -$17.86 -$21.52
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$8.39 -$5.61 -$4.78 -$5.28
Operating activities
Depreciation $0.12 $0.13 $0.12 $0.12
Business acquisitions & disposals
Stock-based compensation $0.59 $0.89 $0.21 $0.17
Total cash flows from operations -$6.55 -$6.61 -$8.02 -$3.1
Investing activities
Capital expenditures -$2.68 -$0.27 -$0.3 -$0.31
Investments
Total cash flows from investing -$2.68 -$0.27 -$0.3 -$0.31
Financing activities
Dividends paid
Sale and purchase of stock -$0.21 $5.85 $0.07
Net borrowings -$1
Total cash flows from financing -$0.21 $4.85 $0.07
Effect of exchange rate -$0.15 -$0.22 -$0.04 -$0.07
Change in cash and equivalents -$9.59 -$2.26 -$8.37 -$3.41
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$16.16 -$16.83 -$17.86 -$21.52
Operating activities
Depreciation $0.4 $0.5 $0.98 $0.94
Business acquisitions & disposals
Stock-based compensation $1.83 $3.37 $2.74 $2.77
Total cash flows from operations -$16.71 -$12.79 -$12.75 -$14.15
Investing activities
Capital expenditures -$0.71 -$0.1 -$0.21 -$0.52
Investments
Total cash flows from investing -$0.71 -$0.1 -$0.21 -$0.52
Financing activities
Dividends paid
Sale and purchase of stock $29.98 $5.68 $9.18 -$0.16
Net borrowings -$0.03 $2.31 $2.37 $11.4
Total cash flows from financing $29.95 $24.35 $10.72 $11.23
Effect of exchange rate -$0.24 $0.32 -$0.02 -$0.11
Change in cash and equivalents $12.3 $11.78 -$2.25 -$3.54
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $46.82M
EBITDA -$21.69M
EBIT -$22.17M
Net Income -$24.05M
Revenue Q/Q 26.01%
Revenue Y/Y 32.63%
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -48.29%
ROE -118.37%
Debt/Equity 1.19
Net debt/EBITDA -0.88
Current ratio 2.46
Quick ratio 1.27